Poolbeg Pharma Sign AI Deal With OneThree Biotech For First Human Challenge Trial
Brad Pryde speaks at the Charlton Morris Using Artificial Discovery in Drug Discovery Webinar
OneThree Biotech and Poolbeg Pharma Partner to Identify New Drug Targets for RSV
OneThree Biotech Partners With Poolbeg Pharma to Identify New Drug Targets and Treatments for Respiratory Syncytial Virus (‘RSV’) https://polaris.brighterir.com/public/poolbeg_pharma/news/rns/story/xqo332r
Is AI Delivering on the Hype? – Commentary From OneThree Biotech
OneThree Biotech Joins Forces with SPARC to Characterize a Key Oncologic Pathway https://www.biospace.com/article/releases/onethree-biotech-joins-forces-with-sparc-to-characterize-a-key-oncologic-pathway/
Carna & OneThree Biotech Partnership Announcement and Overview
Carna & OneThree Biotech Partnership Announcement This webinar will be announcing the partnership between Carna Biosciences and OneThree Biotech. The OneThree Panel will be available through Carna and provide the opportunity to see drug similarity analysis and toxicity predictions. All material presented in the webinar will be provided afterwards. Submit Questions Below Meet Our Presenters! […]
OneThree Biotech Joins Forces with SPARC to Characterize a Key Oncologic Pathway
OneThree Biotech Joins Forces with SPARC to Characterize a Key Oncologic Pathway https://www.biospace.com/article/releases/onethree-biotech-joins-forces-with-sparc-to-characterize-a-key-oncologic-pathway/
AACR 2021: Methodologies for Target ID, Drug Repurposing, and Discovering Biomarkers
OneThree Biotech Announces Novel Methodologies for Identifying Targets, Repurposing Drugs, and Discovering Patients’ Biomarkers at AACR Annual Conference 2021 OneThree will be demonstrating how our AI platforms help to identify targets, repurpose drugs, and discover patients’ biomarkers with three posters at the upcoming American Association for Cancer Research (AACR) 2021 conference. These capabilities have been […]
OneThree’s Workflow to ID Synergistic Drug Combos
OneThree’s Workflow for Identifying Synergistic Drug Combinations Background OneThree Biotech was born out of the largest precision medicine institute in America with the purpose of decreasing the failure rate of bringing therapeutics to market using biology driven artificial intelligence. Our technology was builtin a lab setting; allowing us to engineer our methodologies around real-world results. […]
OneThree’s Workflow for Target and Compound Discovery
OneThree’s Workflow for Target and Compound Discovery Background OneThree Biotech was born out of the largest precision medicine institute in America with the purpose of decreasing the failure rate of bringing therapeutics to market using biology driven artificial intelligence. Our technology was builtin a lab setting; allowing us to engineer our methodologies around real-world results. […]
OneThree’s Workflow for Predicting Drug Toxicity
OneThree’s Workflow for Predicting Drug Toxicity Background OneThree Biotech was born out of the largest precision medicine institute in America with the purpose of decreasing the failure rate of bringing therapeutics to market using biology driven artificial intelligence. Our technology was builtin a lab setting; allowing us to engineer our methodologies around real-world results. While […]
Identifying the Mechanism and New Indications for ONC201
Identifying the Mechanism and New Indications for ONC201 Background OneThree Biotech was born out of the largest precision medicine institute in America with the purpose of decreasing the failure rate of bringing therapeutics to market using biology driven artificial intelligence. Our technology was built in a lab setting; allowing us to engineer our methodologies around […]